Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions.

Autor: Wilcox JA; Department of Neurology, Brain Tumor Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Chukwueke UN; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Aizer AA; Department of Radiation Oncology, Brigham and Women's Hospital / Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Bale TA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Brandsma D; Department of Neuro-Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Brastianos PK; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Chang S; Division of Neuro-Oncology, Department of Neurosurgery, University of San Francisco California, San Francisco, California, USA., Daras M; Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, USA., Forsyth P; Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Garzia L; Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada., Glantz M; Department of Neurosurgery, Penn State College of Medicine, Hershey, Pennsylvania, USA., Oliva ICG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kumthekar P; The Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA., Le Rhun E; Departments of Neurology and Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Nagpal S; Division of Neuro-Oncology, Department of Neurology, Stanford University School of Medicine, Stanford, California, USA., O'Brien B; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pentsova E; Department of Neurology, Brain Tumor Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Remsik J; Laboratory for Immunology of Metastatic Ecosystems, Center for Cancer Biology, VIB, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium., Rudà R; Division of Neuro-Oncology, Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy.; Department of Neurology, Castelfranco Veneto and Treviso Hospitals, Castelfranco Veneto, Italy., Smalley I; Department of Tumor Biology, The Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Taylor MD; Division of Neurosurgery, Department of Surgery, Texas Children's Hospital, Houston, Texas, USA.; Neuro-oncology Research Program, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas., Weller M; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Wefel J; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yang JT; Department of Radiation Oncology, Department of Radiation Oncology, New York University School of Medicine, New York, New York, USA., Young RJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Boire AA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Neurology, Brain Tumor Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Publikováno v: Neuro-oncology [Neuro Oncol] 2024 Oct 03; Vol. 26 (10), pp. 1781-1804.

Demographic and clinical characteristics of patients with metastatic breast cancer and leptomeningeal disease: a single center retrospective cohort study.

Autor: Huppert LA; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. Laura.huppert@ucsf.edu., Fisch S; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Tsopurashvili E; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Somepalle SS; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Salans M; Division of Radiation Oncology, University of California, San Francisco, San Francisco, CA, USA., Vasudevan HN; Division of Radiation Oncology, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Jo Chien A; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Majure M; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Rugo HS; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Balassanian R; Division of Pathology, University of California, San Francisco, San Francisco, CA, USA., Boreta L; Division of Radiation Oncology, University of California, San Francisco, San Francisco, CA, USA., Melisko ME; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Aug; Vol. 206 (3), pp. 625-636. Date of Electronic Publication: 2024 Jun 18.

Nasopharyngeal carcinoma with leptomeningeal metastases has been treated with comprehensive treatment for long-term survival: A case report and literature review.

Autor: Yang Y; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China., Jiang J, Liu Y, Feng S, Bu H

Publikováno v: Medicine [Medicine (Baltimore)] 2024 Jun 07; Vol. 103 (23), pp. e37853.

Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors.

Autor: Barbour AB; Department of Radiation Oncology, University of Washington- Fred Hutchinson Cancer Center, Seattle, WA, USA., Blouw B; Formerly Employed at Biocept, San Diego, CA, USA., Taylor LP; Department of Neurology, University of Washington- Alvord Brain Tumor Center, Seattle, WA, USA., Graber JJ; Department of Neurology, University of Washington- Alvord Brain Tumor Center, Seattle, WA, USA., McGranahan T; Division of Hematology-Oncology, Scripps Cancer Center, La Jolla, CA, USA., Blau M; Department of Radiation Oncology, University of Washington- Fred Hutchinson Cancer Center, Seattle, WA, USA., Halasz LM; Department of Radiation Oncology, University of Washington- Fred Hutchinson Cancer Center, Seattle, WA, USA., Lo SS; Department of Radiation Oncology, University of Washington- Fred Hutchinson Cancer Center, Seattle, WA, USA., Tseng YD; Department of Radiation Oncology, University of Washington- Fred Hutchinson Cancer Center, Seattle, WA, USA., Venur V; Department of Neurology, University of Washington- Alvord Brain Tumor Center, Seattle, WA, USA.; Division of Medical Oncology, University of Washington- Fred Hutchinson Cancer Center, Seattle, WA, USA., Yang JT; Department of Radiation Oncology, University of Washington- Fred Hutchinson Cancer Center, Seattle, WA, USA. Jonathan.t.yang@gmail.com.

Publikováno v: Journal of neuro-oncology [J Neurooncol] 2024 May; Vol. 167 (3), pp. 509-514. Date of Electronic Publication: 2024 Mar 05.

[Intrathecal chemotherapy for leptomeningeal metastases in patients with breast cancer].

Autor: Moskvina EA; Blokhin National Cancer Research Center, Moscow, Russia., Belov DM; Blokhin National Cancer Research Center, Moscow, Russia., Naskhletashvili DR; Blokhin National Cancer Research Center, Moscow, Russia., Mekheda LV; Blokhin National Cancer Research Center, Moscow, Russia., Bekyashev AK; Blokhin National Cancer Research Center, Moscow, Russia.; Russian Medical Academy of Continuing Professional Education, Moscow, Russia., Aleshin VA; Blokhin National Cancer Research Center, Moscow, Russia., Gasparyan TG; Blokhin National Cancer Research Center, Moscow, Russia., Mitrofanov AA; Blokhin National Cancer Research Center, Moscow, Russia., Sevyan NV; Sechenov First Moscow State Medical University, Moscow, Russia., Prozorenko EV; Sechenov First Moscow State Medical University, Moscow, Russia., Tkhazeplov AA; Blokhin National Cancer Research Center, Moscow, Russia., Roshchina KE; Blokhin National Cancer Research Center, Moscow, Russia.

Publikováno v: Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko [Zh Vopr Neirokhir Im N N Burdenko] 2024; Vol. 88 (3), pp. 31-37.